معرفی
Dr. Christopher Yu is a Clinical Lecturer at the Nepean Clinical School, part of the Sydney Medical School within the University of Sydney's Faculty of Medicine and Health. His research focuses on cardiovascular health, cardio-oncology, and medical imaging, particularly addressing cardiac complications from chemotherapy and improving diagnostic techniques for heart conditions. He has contributed to studies like the REDUCE trial (sonothrombolysis in myocardial infarction) and the AGILE-echo trial (AI-guided echocardiography in remote settings).
His work bridges clinical practice and innovation, with recent publications exploring anthracycline cardiotoxicity, coronary artery imaging via AI (TQGDNet), and the role of cardiac MRI in diagnosing MINOCA (myocardial infarction with non-obstructive coronary arteries). He has also evaluated Australia’s cardio-oncology landscape and long-term outcomes of cardiac device-related complications.
Key collaborations include studies on prophylactic strategies to mitigate cancer therapy-induced cardiac damage and optimizing pharmacotherapy cessation post-chemotherapy recovery. His research emphasizes translating advanced imaging and AI tools into clinical applications for better patient outcomes.